These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 17082250)

  • 21. Regulation of c-Ret in the developing kidney is responsive to Pax2 gene dosage.
    Clarke JC; Patel SR; Raymond RM; Andrew S; Robinson BG; Dressler GR; Brophy PD
    Hum Mol Genet; 2006 Dec; 15(23):3420-8. PubMed ID: 17047028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).
    Boucher C; Sandford R
    Eur J Hum Genet; 2004 May; 12(5):347-54. PubMed ID: 14872199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD).
    Lanoix J; D'Agati V; Szabolcs M; Trudel M
    Oncogene; 1996 Sep; 13(6):1153-60. PubMed ID: 8808689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuronal apoptosis inhibitory protein is expressed in developing kidney and is regulated by PAX2.
    Dziarmaga A; Hueber PA; Iglesias D; Hache N; Jeffs A; Gendron N; Mackenzie A; Eccles M; Goodyer P
    Am J Physiol Renal Physiol; 2006 Oct; 291(4):F913-20. PubMed ID: 16735463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-inheritance of a PKD1 mutation and homozygous PKD2 variant: a potential modifier in autosomal dominant polycystic kidney disease.
    Dedoussis GV; Luo Y; Starremans P; Rossetti S; Ramos AJ; Cantiello HF; Katsareli E; Ziroyannis P; Lamnissou K; Harris PC; Zhou J
    Eur J Clin Invest; 2008 Mar; 38(3):180-90. PubMed ID: 18257781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model.
    Leonhard WN; van der Wal A; Novalic Z; Kunnen SJ; Gansevoort RT; Breuning MH; de Heer E; Peters DJ
    Am J Physiol Renal Physiol; 2011 May; 300(5):F1193-202. PubMed ID: 21345977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A truncated polycystin-2 protein causes polycystic kidney disease and retinal degeneration in transgenic rats.
    Gallagher AR; Hoffmann S; Brown N; Cedzich A; Meruvu S; Podlich D; Feng Y; Könecke V; de Vries U; Hammes HP; Gretz N; Witzgall R
    J Am Soc Nephrol; 2006 Oct; 17(10):2719-30. PubMed ID: 16943309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered Hippo signalling in polycystic kidney disease.
    Happé H; van der Wal AM; Leonhard WN; Kunnen SJ; Breuning MH; de Heer E; Peters DJ
    J Pathol; 2011 May; 224(1):133-42. PubMed ID: 21381034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PAX2 is reactivated in urinary tract obstruction and partially protects collecting duct cells from programmed cell death.
    Cohen T; Loutochin O; Amin M; Capolicchio JP; Goodyer P; Jednak R
    Am J Physiol Renal Physiol; 2007 Apr; 292(4):F1267-73. PubMed ID: 17164400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kidney-specific inactivation of the Pkd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice.
    Lantinga-van Leeuwen IS; Leonhard WN; van der Wal A; Breuning MH; de Heer E; Peters DJ
    Hum Mol Genet; 2007 Dec; 16(24):3188-96. PubMed ID: 17932118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of ureteric bud apoptosis rescues nephron endowment and adult renal function in Pax2 mutant mice.
    Dziarmaga A; Eccles M; Goodyer P
    J Am Soc Nephrol; 2006 Jun; 17(6):1568-75. PubMed ID: 16672320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cux1 promotes cell proliferation and polycystic kidney disease progression in an ADPKD mouse model.
    Porath B; Livingston S; Andres EL; Petrie AM; Wright JC; Woo AE; Carlton CG; Baybutt R; Vanden Heuvel GB
    Am J Physiol Renal Physiol; 2017 Oct; 313(4):F1050-F1059. PubMed ID: 28701314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease.
    Harris PC; Bae KT; Rossetti S; Torres VE; Grantham JJ; Chapman AB; Guay-Woodford LM; King BF; Wetzel LH; Baumgarten DA; Kenney PJ; Consugar M; Klahr S; Bennett WM; Meyers CM; Zhang QJ; Thompson PA; Zhu F; Miller JP
    J Am Soc Nephrol; 2006 Nov; 17(11):3013-9. PubMed ID: 17035604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immortalized epithelial cells from human autosomal dominant polycystic kidney cysts.
    Loghman-Adham M; Nauli SM; Soto CE; Kariuki B; Zhou J
    Am J Physiol Renal Physiol; 2003 Sep; 285(3):F397-412. PubMed ID: 12734101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant expression of SPARC and its impact on proliferation and apoptosis in ADPKD cyst-lining epithelia.
    Wang W; Mei C; Tang B; Zhao H; Xu C; Li Z; Shen X; Fu W; Dai B
    Nephrol Dial Transplant; 2006 May; 21(5):1278-88. PubMed ID: 16421164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathogenesis of cystic kidney diseases].
    Walz G
    Verh Dtsch Ges Pathol; 2002; 86():138-44. PubMed ID: 12647363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transforming growth factor-β inhibits cystogenesis in human autosomal dominant polycystic kidney epithelial cells.
    Elberg D; Jayaraman S; Turman MA; Elberg G
    Exp Cell Res; 2012 Aug; 318(13):1508-16. PubMed ID: 22504005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common regulatory elements in the polycystic kidney disease 1 and 2 promoter regions.
    Lantinga-van Leeuwen IS; Leonhard WN; Dauwerse H; Baelde HJ; van Oost BA; Breuning MH; Peters DJ
    Eur J Hum Genet; 2005 May; 13(5):649-59. PubMed ID: 15770226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular genetics and mechanism of autosomal dominant polycystic kidney disease.
    Wu G; Somlo S
    Mol Genet Metab; 2000 Jan; 69(1):1-15. PubMed ID: 10655152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Heterozygosity loss and somatic mutations in type I and II dominant autosomal renal polycystic kidney disease: evidence of a recessive mechanism at a cell level in cystogenesis].
    Pérez-Oller L; Torra R; Badenas C; San Millán JL; Darnell A
    Nefrologia; 2000; 20(2):130-8. PubMed ID: 10853193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.